NextFin news, Chinese scientists from Kaiwa Technology in Guangzhou revealed on August 15, 2025, that they are developing the world's first humanoid robot capable of carrying a pregnancy to term and delivering a live baby. The robot is equipped with an artificial womb that supplies nutrients through a tube, replicating natural gestation.
Dr. Zhang Qifeng, founder and CEO of Kaiwa Technology, stated that the artificial womb technology has reached a mature stage and is now being integrated into the robot's abdomen to enable interaction between the robot and a real person to achieve pregnancy. The company plans to launch a prototype by 2026, with an estimated price of about 100,000 yuan (approximately 11,500 euros or 14,000 USD).
The robot is designed to simulate the entire reproductive process from conception to birth. However, details on how fertilization and embryo implantation will be performed have not been disclosed. The announcement was made public through an interview on Duoyin, the Chinese version of TikTok.
The development has sparked mixed reactions on Chinese social media. Critics raise ethical concerns about the technology, arguing it is unnatural and deprives the fetus of maternal connection. Supporters see it as a potential solution to spare women from the physical burdens of pregnancy and assist those facing infertility.
Previous scientific advances include the use of artificial wombs to sustain premature lambs, but this robot aims to support fetal development from conception to birth. Dr. Zhang mentioned that discussions with Guangdong provincial authorities are ongoing to address legal and policy frameworks.
The project was presented at the 2025 World Robotics Conference in Beijing. It is linked to Nanyang Technological University in Singapore through Dr. Zhang's academic affiliation.
This innovation marks a significant milestone in reproductive technology, though medical experts remain cautious about replicating complex biological processes such as hormone secretion and immune interactions during pregnancy.
Explore more exclusive insights at nextfin.ai.
